Cipher Pharmaceuticals (CPH) Earnings Date, Estimates & Call Transcripts

C$8.60
-0.21 (-2.38%)
(As of 12:54 PM ET)

Earnings Summary

Upcoming
Earnings Date
May. 9Estimated
Actual EPS
(Mar. 14)
C$0.41 Beat By C$0.26
Consensus EPS
(Mar. 14)
C$0.15
Skip Charts & View Estimated and Actual Earnings Data

CPH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CPH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cipher Pharmaceuticals Analyst EPS Estimates

Current Year EPS Consensus Estimate:C$0.60 EPS

CPH Earnings Date and Information

Cipher Pharmaceuticals last issued its quarterly earnings results on March 14th, 2024. The reported C$0.41 earnings per share for the quarter, topping the consensus estimate of C$0.15 by C$0.26. The company had revenue of C$6.70 million for the quarter, compared to analysts' expectations of C$7.31 million. Cipher Pharmaceuticals has generated C$1.09 earnings per share over the last year (C$1.09 diluted earnings per share) and currently has a price-to-earnings ratio of 7.9. Cipher Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.

Cipher Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2024
Estimated)
------- 
3/14/2024Q4 2023C$0.15C$0.41+C$0.26C$0.41C$7.31 millionC$6.70 million
11/9/2023Q3 2023C$0.12C$0.36+C$0.24C$0.36C$6.68 millionC$8.14 million
8/10/2023Q2 2023C$0.15C$0.16+C$0.01C$0.16C$7.46 millionC$7.10 million
5/11/2023Q1 2023-C$0.14+C$0.14C$0.14C$7.83 millionC$6.61 million
3/16/2023Q4 2022-C$1.05+C$1.05C$1.05C$7.43 millionC$6.67 million
11/10/2022Q3 2022-C$0.13+C$0.13C$0.13C$7.81 millionC$6.26 million
8/11/2022Q2 2022-C$0.10+C$0.10C$0.10C$8.28 millionC$7.09 million
5/12/2022Q1 2022-C$0.08+C$0.08C$0.08C$7.18 millionC$4.97 million
3/17/2022Q4 2021-C$0.14+C$0.14C$0.14C$7.17 millionC$7.44 million
11/11/2021Q3 2021-C$0.04+C$0.04C$0.04C$7.43 millionC$5.68 million
8/12/2021Q2 2021-C$0.12+C$0.12C$0.12C$6.02 millionC$7.53 million
5/13/2021Q1 2021C$0.11C$0.13+C$0.02C$0.20C$7.00 millionC$6.90 million

Cipher Pharmaceuticals Earnings - Frequently Asked Questions

When is Cipher Pharmaceuticals's earnings date?

Cipher Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on CPH's earnings history.

Did Cipher Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Cipher Pharmaceuticals (TSE:CPH) reported C$0.41 earnings per share (EPS) to beat the analysts' consensus estimate of C$0.15 by C$0.26. Learn more on analysts' earnings estimate vs. CPH's actual earnings.

How much revenue does Cipher Pharmaceuticals generate each year?

Cipher Pharmaceuticals (TSE:CPH) has a recorded annual revenue of C$21.16 million.

How much profit does Cipher Pharmaceuticals generate each year?

Cipher Pharmaceuticals (TSE:CPH) has a recorded net income of C$20.38 million. CPH has generated C$1.09 earnings per share over the last four quarters.

What is Cipher Pharmaceuticals's price-to-earnings ratio?

Cipher Pharmaceuticals (TSE:CPH) has a trailing price-to-earnings ratio of 7.89 and a forward price-to-earnings ratio of 14.24.


More Earnings Resources from MarketBeat

This page (TSE:CPH) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners